Keratinocyte growth factor (KGF) is a paracrine mediator of epithelial cell growth. To examine the direct effects of KGF on the morphogenesis of the epidermis, we generated skin equivalents in vitro by seeding human keratinocytes on the papillary surface of acellular dermis and raising them up to the air-liquid interface. KGF was either added exogenously or expressed by keratinocytes via a recombinant retrovirus encoding KGF. KGF induced dramatic changes to the 3-dimensional organization of the epidermis including pronounced hyperthickening, crowding, and elongation of the basal cells, flattening of the rete ridges, and a ripple-like pattern in the junction of stratum corneum and granular layers. Quantitative immunostaining for the proliferation antigen, Ki67, revealed that in addition to increasing basal proliferation, KGF extended the proliferative compartment by inducing suprabasal cell proliferation. KGF also induced expression of the integrin ␣5␤1 and delayed expression of keratin 10 and transglutaminase. However, barrier formation of the epidermis was not disrupted. These results demonstrate for the first time that a single growth factor can alter the 3-dimensional organization and proliferative function of an in vitro epidermis. In addition to new strategies for tissue engineering, such a well-defined system will be useful for analyzing growth factor effects on the complex links between cell proliferation, cell movement and differentiation within a stratified tissue.-Andreadis, S. T., Hamoen, K. E., Yarmush, M. L., Morgan, J. R. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 15, 898 -906 (2001) 
Although much is known about the influence of numerous growth factors on the proliferation, migration, and function of cells grown in vitro using conventional flat 2-dimensional cultures, little is known about the role of growth factors on the normal 3-dimensional architecture of tissues. The epidermis is one of only a few tissues where it is possible to culture its principal cell (the keratinocyte) and use these cultured cells to reconstitute a stratified and fully differentiated human tissue in vitro (1, 2) . Although these skin equivalents have been used clinically to repair burns and wounds (3, 4) and are being considered for gene therapy strategies (5) (6) (7) (8) (9) (10) (11) , there has been little use of these skin equivalents to study the factors that control the proliferation, differentiation, and 3-dimensional organization of the epidermis. Such information is important to understand the factors that control epidermal morphogenesis, pathways to diseases of the epidermis, and the design of improved tissue engineering strategies for the repair of defective skin.
Diploid human keratinocytes are readily cultured in vitro; when seeded on the surface of analogs of the dermis and exposed to the air/liquid interface, the cells will stratify, differentiate, and form an epidermis complete with basal, spinous, granular, and cornified layers (12) . We used this system to study the effects of keratinocyte growth factor (KGF). KGF, a member of the fibroblast growth factor family (FGF-7), is a paracrine mediator of epithelial cell growth (13) that is expressed by stromal cells in a variety of tissues including lung, prostate, mammary gland, stomach, bladder, and skin (14) . Expression of KGF is restricted to cells of mesenchymal origin, whereas its mitogenic activity is restricted to epithelial cells (14) and is mediated through the KGF receptor (KGFR), a splice variant of FGF-2 receptor encoded by the gene fgfr-2 (15, 16) . KGF is thought to play an important role in tissue development and response to cutaneous injury and has been implicated in tissue morphogenesis, especially in those tissues whose development is dependent on mesenchymal-epithelial interactions (17, 18) . Targeting KGF expression to the basal keratinocytes of a developing mouse epidermis caused epidermal hyperthickening accompanied by alterations in epidermal growth and differentiation (19) . Expression of KGF is stimulated (20) during normal wound healing, and this up-regulation is significantly reduced and delayed in diabetic (21) and glucocorticoid-treated mice (22) .
Due to the complexity of the in vivo setting and the presence of numerous cell types, it is often difficult to establish direct cause-and-effect relationships between a growth factor and a change to tissue organization. Therefore, we took advantage of the skin equivalent system to study KGF's effects on a 3-dimensional human epidermis reconstituted by a single cell type. KGF either was added exogenously as a recombinant protein or was produced by keratinocytes genetically modified to express the KGF gene. KGF induced significant changes to the cellular organization of the in vitro epidermis including an increase in epidermal thickness, crowding and elongation of the cells of the basal layer, and an induction of suprabasal cell proliferation. Although terminal differentiation was delayed, normal granular and cornified layers were produced. Most of KGF's effects appear to target the proliferative compartment of the epidermis and possibly are mediated by its induction of ␣5␤1, an integrin that might increase the adhesiveness of the basal cells. These results support the importance of KGF in controlling the proliferation of the epidermis and demonstrate the usefulness of using skin equivalents to investigate the effects of growth factors on the 3-dimensional organization and function of the epidermis.
MATERIALS AND METHODS

Keratinocyte culture and production of skin equivalents
Normal human keratinocytes derived from neonatal foreskins were isolated and grown following methods by Rheinwald and Green (23) . Primary cultures of keratinocytes were established by cocultivation with 3T3-J2 mouse fibroblasts (originally provided by H. Green, Harvard Medical School, Boston, Mass.) pretreated with 15 g/ml mitomycin C (Boehringer Mannheim, Indianapolis, Ind.). The keratinocyte culture medium was a 3:1 mixture of Dulbecco's modified Eagle's medium (DMEM, high glucose) (Gibco/BRL, Gaithersburg, Md.) and Ham's F12 medium (Gibco./BRL) supplemented with adenine, 1.8 ϫ 10 Ϫ4 M (Sigma Chemical, St. Louis, Mo.); cholera toxin, 10 Ϫ10 M (Vibrio cholerae, Type Inaba 569 B; Calbiochem, La Jolla, Calif.); hydrocortisone, 0.4 g/ml (Calbiochem); insulin, 5 g/ml (Novo Nordisk, Princeton, N.J.); transferrin, 5 g/ml (Boehringer Mannheim); triiodol-thyronine, 2 ϫ 10 Ϫ9 M (Sigma); and penicillin-streptomycin, 100 IU/ml-100 g/ml (Boehringer Mannheim). Epidermal growth factor (Collaborative Biomedical Products, Bedford, Mass.) was added at 10 ng/ml with the first medium change 3 days after cell isolation. Cultures were incubated in a humidified 10% CO 2 atmosphere at 37°C and medium was changed every 3-4 days. Keratinocytes were subcultured by first removing the feeder layer cells with a trypsin-EDTA wash (1 min), then treating keratinocytes with trypsin-EDTA for 10 -15 min and reseeding them on mitomycin-C 3T3-J2 mouse fibroblasts.
Swiss mouse 3T3-J2 and virus producer cell lines were passaged twice a week in DMEM (high glucose) supplemented with 10% bovine calf serum (HyClone, Logan, Utah) and penicillin-streptomycin, (100 IU/ml to 100 g/ml) and incubated in a humidified 10% CO 2 atmosphere at 37°C.
Keratinocytes were seeded onto the papillary side of acellular dermis using methods similar to those previously described (24) with slight modifications of media described by Ponec et al. (12) . Acellular dermis was placed into 35 mm tissue culture dishes; cells in keratinocyte seeding medium (described below) were seeded onto the surface (5ϫ10 5 cells/cm 2 ). After ϳ2 h, the skin equivalents were submerged in keratinocyte seeding medium for 24 h. Keratinocyte seeding medium was a 3:1 mixture of DMEM (high glucose) (GIBCO-BRL) and Ham's F-12 medium (GIBCO-BRL) supplemented with 1% FBS, 10 Ϫ10 M cholera toxin (Vibrio cholerae, Type Inaba 569 B; Calbiochem), 0.2 g/ml hydrocortisone (Calbiochem), 5 g/ml insulin (Novo Nordisk, Princeton, N.J.), 50 g/ml ascorbic acid (Sigma), and 100 IU/ml and 100 g/ml penicillin-streptomycin (Boehringer Mannheim). After 24 h, keratinocyte seeding medium was removed and the skin equivalents were submerged for an additional 48 h in a keratinocyte priming medium. Keratinocyte priming medium was composed of keratinocyte seeding medium supplemented with 24 M bovine serum albumin (BSA; Sigma), 1.0 mM l-serine (Sigma), 10 M l-carnitine (Sigma), and a mixture of fatty acids: 25 M oleic acid, (Sigma), 15 M linoleic acid (Sigma), 7 M arachidonic acid (Sigma), and 25 M palmitic acid (Sigma) (25) . After 48 h in priming medium, skin equivalents were placed on stainless steel screens, raised to the air-liquid interface, and cultured with an air-liquid interface medium composed of serum-free keratinocyte priming medium supplemented with 1.0 ng/ml epidermal growth factor (Collaborative Biomedical Products).
Measurements of surface electrical capacitance
Formation of epidermal barrier was measured with a dermal phase meter (DPM 9003; NOVA Technology, Gloucester, Mass.) by placing the 6 mm sensor probe on the surface of the composite grafts. The dermal phase meter measures surface capacitance, which is a measure of surface skin hydration, by integrating measurements at different frequencies of the applied alternating current (26) . Ten serial readings were recorded at 1 s intervals and were immediately displayed on the LCD screen of the instrument and stored in a computer for further analysis. Instrument readings were converted to pF by use of the formula (27) :
The initial reading (tϭ1 s) is reported here; the conclusions remained unchanged when subsequent readings (tϭ10 s) were used.
Recombinant retrovirus
A cDNA encoding human KGF was kingly provided by William LaRochelle of National Cancer Institute and was inserted into the NcoI and BamHI site of the MFG retroviral vector (28) by a two-step procedure. MFG vector DNA was digested with NcoI and BamHI and gel purified. Vector DNA was ligated to two annealed oligonucleotides encoding the first few amino acids of KGF (5Ј-CATGCACAAATGGATACTGACATG-3Ј and 5Ј-GATC-CATGTCAGTATCCATTTGTG-3Ј). MFG, with this small oligo insert, was isolated, digested with BamHI, treated with calf intestinal phosphatase, and gel purified. The remainder of the KGF open reading frame was prepared by PCR and ligated into this vector. The PCR product encoding the rest of KGF was prepared using 5Ј-CATGCACAAATGGATACTGACATG-3Ј as a forward primer and 5Ј-AGTCCAGGATCCAGATCTTAAGT-TATTGCCATAGGAAGAAAGTGG-3Ј as a reverse primer. The PCR product was digested with BamHI and gel purified before ligation into the final vector. The fidelity of the entire insert in the final MFG-KGF vector was verified by DNA sequencing. To generate a virus-producing cell line, MFG-KGF plasmid DNA was transfected into individual ⌿-CRIP packaging cell lines as described (5) .
Measurement of KGF production
The time course of KGF secretion by genetically modified cells was determined by an enzyme-linked immunosorbent assay (ELISA). ELISA 96-well plates (Fisher Scientific, Agawan, Mass.) were coated with 100 l of a 1.0 g/ml mouse antihuman KGF monoclonal antibody (R&D Systems Minneapolis, Minn.) in PBS/0.1% BSA by overnight incubation at room temperature. The next day, the antibody was removed; the plate washed three times with buffer solution (PBS/ 0.05% Tween 20, pH 7.4) and blocked with 300 l of PBS with 1% BSA, 5% sucrose, and 0.05% NaN 3 for 1 h at room temperature. The plate was washed three times with buffer solution and the conditioned medium containing KGF along with KGF standards (R&D Systems) was added in triplicate (100 l per well) for 2 h at room temperature. The plate was washed three times and 100 l of biotinylated goat polyclonal anti-hKGF detection antibody (R&D Systems) was added at 200 ng/ml in diluent (0.1% BSA, 0.05% Tween 20 in Trisbuffered saline, pH 7.3) for 2 h at room temperature. After three washes, 100 l of a horseradish peroxidase (HRP) -conjugated avidin (Zymed Laboratories, South San Francisco, Calif.) was added at a dilution of 1:5,000 in PBS/0.1% BSA for 1 h at room temperature. The substrate (10 mg o-phenylenediamine dihydrochloride) and 10 l of H 2 O 2 in 25 ml of substrate buffer (5.1 mg/ml citric acid mono-hydrate and 13.78 mg/ml Na 2 HPO 4 ⅐7H 2 0 in dH 2 O) were added (100 l per well) and the reaction was allowed to proceed for 10 min before addition of 50 l per well of 8N H 2 SO 4 (stop solution). The optical density was read at 490 -650 nm with an ELISA plate reader (ThermoMax plate reader, Molecular Devices, Palo Alto, Calif.).
Histology and immunohistochemistry
To detect the presence of Ki67, keratin 10, and transglutaminase the skin equivalents were fixed in 4% paraformaldehyde in PBS for 4 h at 4°C, followed by treatment with 0.1M ice-cold glycine for 1 h and overnight incubation in 0.6M sucrose solution at 4°C. Tissues were embedded in OCT and placed in dry ice. 
RESULTS
KGF induces hyperproliferation of an in vitro epidermis
To test the effects of KGF, we generated skin equivalents in vitro by seeding human keratinocytes on the papillary surface of acellular dermis and raising them up to the air-liquid interface. Within 7 days, these skin equivalents differentiated and formed a well-stratified epidermis complete with basal, spinous, granular, and cornified layers. Keratinocytes genetically modified with a recombinant retrovirus encoding KGF secreted KGF protein at a rate of (4.3 ng/10 7 cells/24 h); this secretion persisted for at least 4 wk in culture, when the modified cells were used to make skin equivalents (Fig.  1) . Skin equivalents secreting KGF showed striking differences in tissue morphology as compared to controls (Fig. 2) . After 1 wk at the air/liquid interface, the thickness of the KGF-expressing epidermis was increased mainly because of an increase in the suprabasal and spinous cell layers. There was a slight decrease in the stratum corneum as well, probably due to a delay in differentiation. The density of the cells in the basal layer was also markedly increased and the cells were tightly packed and highly elongated. Similar results were obtained when various concentrations of recombinant KGF protein were added (25 and 100 ng/ml). Increased thickness of KGF-treated and KGF-expressing skin equivalents was also present after 2 wk at the air/liquid interface.
Quantitation of the number of cells per unit length of basement membrane showed that basal cell density was ϳ50% higher in the KGF epidermis vs. control epidermis at 1 wk (Fig. 2) . Addition of exogenous KGF also increased basal cell number, and this increase was independent of the KGF concentrations tested (25-100 ng/ml). Basal cell density was also increased at 2 wk Another change to the epidermis in response to KGF was the flattening of the basal layer and the disappearance of the rete ridges. In controls, keratinocytes filled in and preserved the typical rete ridge pattern characteristic of the acellular dermis. In contrast, the epidermal/dermal interface was flattened and the rete ridges in KGF-expressing and KGF-treated skin equivalents were not as obvious.
The KGF-expressing epidermis also showed unusual ripple-like patterns at the junction of the granular and cornified layers, in contrast to controls, where this junction was mostly flat in appearance. These undula- tions were also apparent in skin equivalents treated with the highest dose of KGF (100 ng/ml).
KGF increases basal cell proliferation and induces suprabasal cell proliferation
To determine KGF's influence on cell proliferation, skin equivalents were stained for the nuclear proliferation antigen Ki67 (brown) and counterstained with hematoxylin (blue) (Fig. 3) . In control skin equivalents, Ki67-positive cells were largely confined to the basal cell layer. In KGF-expressing and KGF-treated skin equivalents, not only was the number of Ki67-positive basal cells increased by twofold (from 50 to 100%; data not shown), but a significant proportion of Ki67-positive cells was also found in the suprabasal cell layers. At low KGF concentrations (25 ng/ml), there was approximately a fourfold increase in the number of Ki67-positive cells, but only a twofold increase at higher KGF concentrations (50 and 100 ng/ml). The number of Ki67-positive cells of KGF-expressing and KGF-treated skin equivalents subsided to the levels of control grafts by 2 wk at the air/liquid interface and there was still evidence of suprabasal cell proliferation.
KGF delays differentiation
To investigate the effect of KGF on differentiation, sections were stained for keratin-10 (K10) and transglutaminase (TGase I) (19, 29, 30) . In control epidermis (days 7 and 14), K10 and TGase I were expressed in all cell layers except for the basal cells (Fig. 4 and Fig. 5) . In KGF-expressing and KGF-treated epidermis, not only was the basal cell layer negative for these differentiation markers, but an additional 3-4 suprabasal cell layers were also negative. These K10 and TGase I negative cell layers coincided with the Ki67-positive cells.
KGF stimulates ␣5␤1 integrin expression
Since KGF had induced major changes to the cellular organization of the epidermis, we stained skin equivalents for alterations to integrin expression. When stained for ␣5␤1, controls had little if any expression, whereas KGF-expressing and KGF-treated skin equivalents had strong staining for ␣5␤1 throughout the basal and suprabasal layers (Fig. 6) . A preponderance of staining for ␣5␤1 in the basal cell layer was localized to the basal domain of the basal cells.
KGF does not alter the barrier function
To determine whether KGF's perturbation of epidermal structure also disrupted barrier formation, we measured the surface electrical capacitance (SEC) of control, KGF-expressing and KGF-treated skin equivalents. SEC is a measure of the surface hydration of the skin and has been used to monitor epidermal barrier function (27, (31) (32) (33) . SEC levels for control and KGF skin equivalents were high at days 1 and 3 after lifting to the air-liquid interface. During this transition time, the cells are stratifying, differentiating and forming a barrier in response to the air (Fig. 7) . By day 4 and beyond, SEC declined to a low and steady level and there was no significant difference between control and KGF skin equivalents.
DISCUSSION
Previous studies with transgenic mice where KGF expression is targeted to the skin or where the receptor Figure 1 . Genetically modified keratinocytes and skin equivalents secrete KGF. Human keratinocytes genetically modified with a recombinant retrovirus encoding KGF were grown to confluence on plastic (A) or used to generate skin equivalents by seeding on the surface of acellular dermis and raising to the air/liquid interface (B). Aliquots of the culture medium were removed and the levels of KGF quantified by ELISA. Secretion of KGF by control unmodified cells was undetectable.
for KGF is disrupted have suggested that KGF has an important role in epidermal proliferation, differentiation, and wound healing (19, 20, 34, 35) . However, it is difficult to reach conclusions about the direct actions of KGF on the epidermis in vivo, because skin has several other cell types in addition to keratinocytes that could be influenced by transgene expression and, during mouse development, unknown compensatory mechanisms may operate in response to transgene expression. Moreover, species differences could exist between mouse and human keratinocytes.
Using an in vitro differentiated skin equivalent system, we show that KGF induces dramatic changes to the proliferation and 3-dimensional organization of the human epidermis. These changes include hyperthickening of the epidermis, an increase in proliferating cells; an elongation of basal cell morphology and an increase in basal cell density, an induction of suprabasal cell proliferation; a delay in differentiation, an induction of ␣5␤1 expression; the loss of rete ridges and the formation of undulations in the junction of the granular and cornified layers. Since this skin equivalent system has only one cell type (human keratinocytes), we can conclude that KGF is able to influence not only cell proliferation, but the 3-dimensional organization of the epidermis as well, and that no other cell types are needed to induce these hyperproliferative changes to the epidermis. These changes were manifest when either recombinant KGF protein was added or if the cells were genetically modified to produce their own KGF.
In the normal epidermis, cell proliferation and discrete steps of differentiation occur at distinct spatial locations in the tissue. Proliferation is confined to the basal layer and there is a steady upward migration and progressive differentiation of cells leading to the formation of the granular and cornified layers. Our data demonstrate that KGF alters this spatial control of proliferation and gives rise to suprabasal cell proliferation. Under normal conditions, keratinocytes that detach from the basal lamina lose their growth potential, and this process is linked to the onset of terminal differentiation (36, 37) . Thus, KGF is able to circumvent this process, possibly by substituting for those signals from the basal lamina that preserve growth potential. Even though the epidermis of the mice expressing KGF was hyperproliferative, there was no evidence of suprabasal cell proliferation (19) .
We also show for the first time that KGF induces ␣5␤1 expression. ␣5␤1 binds fibronectin, and loss of its activity has been linked to migration of cells from the basal layer and terminal differentiation (37, 38) . By stimulating ␣5␤1 expression, KGF may enhance the adhesive properties of basal keratinocytes. In fact, a preponderance of ␣5␤1 protein in KGF-treated skin equivalents is localized to the basal domain of the basal cells. This increase in adhesion may slow the upward migration of basal cells, which in combination with an enhanced rate of proliferation could explain our observation that KGF induces crowding of the basal layer.
Another 3-dimensional change mediated by KGF in our experiments is the loss of rete ridges. The acellular dermis used as a substrate for the formation of an epidermis has a complex surface topography because it retains the papillary projections (24) . When keratinocytes are seeded on the surface of this material, they settle in between the papillary projections and reform rete ridges. In the presence of KGF, these rete ridges were not formed and we observed a flattening of the epidermal-dermal junction. One explanation might be that the increased proliferation and the resulting crowding of the basal layer forced a stretching or flattening of the epidermal-dermal junction. Consistent with this interpretation is the increased expression of ␣5␤1 and its location to the basal domain of basal cells. Another explanation might be that KGF induces remodeling of the papillary projections by induction of various metalloproteases (39 -41) .
An interesting observation was KGF's effect on the junction between the granular and cornified layers. In contrast to the relatively flat interface in controls, high-dose KGF and cells expressing KGF produced undulations in this interface. The cause of this change is unclear, but it may be linked to the increased basal cell density. As this excess of cells moves upward and differentiates, there may be too many cells to be accommodated by a simple flat interface and so an undulating interface of increased surface area is formed. Alternatively, these undulations could arise if the rate of upward migration of cells was not homogenous throughout the skin equivalent. Localized areas where the rate of migration was increased would also have increased numbers of cells arriving at the granular/cornified interface, and undulations might form to accommodate these cells.
Changes to the 3-dimensional organization of the epidermis also occur in the hyperproliferative disease psoriasis. Clearly the immune system plays a critical role in this disease (42) ; however, the nature of the molecular signals that activates the epidermis to undergo such significant changes to proliferation and cell-cell organization is largely unknown. Our results demonstrate that in the absence of immune cells, KGF mediates several but not all of the changes to the epidermis characteristic of psoriasis such as hyperproliferation, suprabasal proliferation, and induction of ␣5␤1 localized to the basal domain of the basal cells (43) . Our data are also consistent with a previous report demonstrating that KGF and its receptor were up-regulated in Figure 5 . KGF delays the production of transglutaminase. Skin equivalents, control (CTRL), genetically modified to express KGF (KGF-modified) or treated with exogenous KGF (25 or 100 ng/ml), were cultured at the air/liquid interface. On days 7 and 14, cryosections were stained for transglutaminase (40ϫ). Figure 6 . KGF elevates ␣5␤1 expression. Skin equivalents, control (CTRL) and genetically modified to express KGF (KGFmodified), were fixed on day 7 in vitro and cryosections (6 m) were stained for ␣5␤1 (20ϫ). psoriasis and that this subsided in response to an antiproliferative agent (44) .
In summary, KGF induces dramatic changes to the organization of the proliferative cells of the epidermis possibly by its induction of proliferation and an increase in adhesiveness through ␣5␤1. These data demonstrate for the first time that a growth factor such as KGF can induce significant changes to the 3-dimensional organization and function of a skin equivalent in vitro and provide a model system for further understanding of KGF's direct effects on the epidermis. Moreover, KGF-treated or KGF-expressing grafts may be useful as part of a tissue engineering/gene therapy approach to repairing defects of the skin.
This work was supported in part by the National Institutes of Health (HD-28528) and the Shriners Hospitals for Children. We gratefully acknowledge Robert Crowther of Shriners Morphology Core for his help in histological preparations and immunostaining. Figure 7 . KGF does not affect barrier function as measured by surface electrical capacitance. Skin equivalents, control (CTRL), genetically modified to express KGF (KGF-modified) or treated with exogenous KGF (25 or 100 ng/ml), were cultured at the air/liquid interface. Surface electrical capacitance was measured daily with a dermal phase meter by placing the 6 mm sensor probe on the surface of triplicate grafts. The initial measurement (tϭ1 s reading) is reported after converting the instrument reading in picofarads (pF).
